⌘K

Login Start Free

Home/Filings/144/0001628280-26-000951

144//SEC Filing

Werewolf Therapeutics, Inc. 144

Accession 0001628280-26-000951

CIK 0001691428other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:56 PM ET

Size

350.0 KB

Accession

0001628280-26-000951

Documents

2 files

Issuer

UBS Oncology Impact Fund L.P.

CIK 0001691428

Entity typeother

IncorporatedCayman Islands

Related Parties

1

filerCIK 0001691428

Filing Metadata

Form type: 144
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 4:56 PM ET
Size: 350.0 KB

View on SEC.gov